Skip to main content

Advertisement

Log in

Stress and melanoma: increasing the evidence towards a causal basis

  • Short Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Melanoma is a multifactorial disease with a strong genetic component and known risk factors such as excessive ultraviolet exposure, intermittent sunburns and fair skin type. The prognosis is poor if diagnosis is delayed, in spite of recent treatment advances. Evidence is mounting that the incidence of melanoma is higher in the immunosuppressed and individuals with highly stressful occupations. We present a case series of individuals diagnosed with multiple cutaneous melanomas over a few months to 1 year. All had encountered psychological stressors in their lives, and the melanomas were diagnosed briefly after encountering these stressors. No known causes of immunosuppression were detected to explain the sporadic occurrence of melanomas in these individuals. There is evidence in the current literature that stress can lead to immune disregulation, predisposing an individual to various disease states including melanoma. Stress hormones such as norepinephrine have been shown to cause upregulation of cytokines such as Interleukin 6 and 8, which are proangiogenic and support tumour progression. Coupled with genetic and environmental factors, stress appears to play a role in melanoma formation and progression. Large prospective studies are required to study the link between stress and melanoma and gain further insight into the etiology of melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Cancer in Australia 2012: an overview. Australian Institute of Health and Welfare (2012) Available via AIHW http://www.aihw.gov.au/publication-detail/?id=60129542359. Accessed December 11, 2012

  2. Duffy K, Grossman D (2012) The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic and clinical aspects. J Am Acad Dermatol. doi:10.1016/j.jaad.2012.03.013

  3. Fagundes CP, Glaser R, Johnson SL et al (2012) Basal cell carcinoma stressful life events and the tumor environment basal cell carcinoma. Arch Gen Psychiatry 69:618–626

    Article  PubMed  Google Scholar 

  4. Goymer P (2006) Tumorigenesis: stress and cancer. Nat Rev Cancer 6:658–659

    Article  CAS  Google Scholar 

  5. Holmes TH, Rahe RH (1967) The social readjustment rating scale. J Psychosom Res 11:213–218

    Article  PubMed  CAS  Google Scholar 

  6. Hussein MR (2004) Genetic pathways to melanoma tumorigenesis. J Clin Pathol 57:797–801

    Article  PubMed  CAS  Google Scholar 

  7. Nilsson MB, Langley RR, Fidler IJ (2005) Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65:10794–10800

    Article  PubMed  CAS  Google Scholar 

  8. Penninx BW, Guralnik JM, Pahor M et al (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888–1893

    Article  PubMed  CAS  Google Scholar 

  9. Pfeifer GP, Besaratinia A (2012) UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci 11:90–97

    Article  PubMed  CAS  Google Scholar 

  10. Rahe RH, Meyer M, Smith M et al (1964) Social stress and illness onset. J Psychosom Res 8:35–44

    Article  Google Scholar 

  11. Reiche EMV, Morimoto HK, Nunes SMV (2005) Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 17:515–527

    Article  PubMed  Google Scholar 

  12. Rigel DS (2010) Epidemiology of melanoma. Semin Cutan Med Surg 29:204–209

    Article  PubMed  CAS  Google Scholar 

  13. Sanzo M, Colucci R, Arunachalam M et al (2010) Stress as a possible mechanism in melanoma progression. Dermatol Res Pract. doi:10.1155/2010/483493

  14. Simonetti O, Lucarini G, Brancorsini D et al (2002) Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 95:1963–1970

    Article  PubMed  CAS  Google Scholar 

  15. Scarparo AC, Sumida DH, Patrao MT et al (2004) Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. Arch Dermatol Res 296(3):112–119

    Google Scholar 

  16. Yang EV, Kim SJ, Donovan EL et al (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23:267–275

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the contribution of David Weedon AO MD FRCPA FCAP (Hon) in the review of the histopathology slides for these cases.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudipta Sinnya.

Additional information

The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinnya, S., De’Ambrosis, B. Stress and melanoma: increasing the evidence towards a causal basis. Arch Dermatol Res 305, 851–856 (2013). https://doi.org/10.1007/s00403-013-1373-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1373-2

Keywords

Navigation